Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07102082

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand

Ifluence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effect

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
Roswell Park Cancer Institute · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.

Detailed description

Primary Objectives: To assess the influence of smokeless tobacco products' modified risk claims on: 1. Product demand (measured as willingness to pay in USD) using an experimental auction approach; and 2. Perceived risk of tobacco-associated diseases as assessed using questionnaire-based measures.

Conditions

Interventions

TypeNameDescription
BEHAVIORALModified Risk - NoneParticipants view ads with no modified risk claim
BEHAVIORALModified Risk ClaimParticipants view ads with a modified risk claim

Timeline

Start date
2025-09-25
Primary completion
2026-11-30
Completion
2026-11-30
First posted
2025-08-03
Last updated
2025-12-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07102082. Inclusion in this directory is not an endorsement.